Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study

Clinical and Economic Burden Associated With Anti-Cytomegalovirus (CMV) Prophylaxis Therapies in Adult Kidney Transplant Recipients (LECOCYT): An Observational Study

The incidence of leukopenia and neutropenia associated with cytomegalovirus (CMV) prophylaxis in kidney transplant (KT) recipients is not well established. LECOCYT, a prospective observational multicenter study, aimed to investigate the clinical and economic burdens of CMV prophylaxis during the fir...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nassim Kamar, Hannah Kaminski, Christophe Masset, Claire Castagné, Guilhem Tournaire, Xavier Bourge, Lionel Bensimon, Moustafa Naja, Stéphanie Degroote, Isabelle Durand-Zaleski, Christophe Legendre
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Transplant International
Subjects:	cytomegalovirus prophylaxis economics ganciclovir valganciclovir kidney transplant
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14342/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Progress and Challenges in the Management of Congenital Cytomegalovirus Infection
by: Weronika Szulc, et al.
Published: (2024-11-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

Congenital cytomegalovirus infection: features of the clinical course and catamnesis according to own observations
by: E. V. Antsiferova, et al.
Published: (2022-10-01)

Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis
by: Leonardo Januário Campos Cardoso, et al.
Published: (2025-03-01)

Co-infection of cytomegalovirus and Leishmania without splenomegaly resulting in immunosuppression in an HIV-negative patient
by: Inder Preet Singh Bhatia, et al.
Published: (2024-10-01)

Hearing loss in children with congenital cytomegalovirus infection
by: Gonçalo Caetano Oliveira, et al.
Published: (2023-11-01)

PE-028 Análise de Custo-Minimização entre Ganciclovir e Valganciclovir para o Tratamento da Retinite por Citomegalovírus em Pessoas Vivendo com o Vírus da Imunodeficiência Humana
by: Álex Brunno do Nascimento Martins, et al.
Published: (2025-03-01)

CMV Infection Risk Factors and Viral Dynamics After Valganciclovir Prophylaxis: 10 Years of Experience in Lung Transplant Recipients
by: Sarela García-Masedo Fernández, et al.
Published: (2024-11-01)

Cytomegalovirus reactivation following hematopoietic stem cell transplantation
by: Sanjeev Kumar Sharma, et al.
Published: (2013-12-01)

Comprehensive insights into cytomegalovirus anterior segment infections: A narrative review
by: Yih-Shiou Hwang, et al.
Published: (2025-04-01)

Transient Azoospermia Induced by Valganciclovir Treatment for Cytomegalovirus Infection in a Reproductive Male After Kidney Transplant: A Case Report
by: Kosuke Mieda, et al.
Published: (2025-07-01)

Changes in Neutrophil Count During Valganciclovir Therapy for Symptomatic Congenital Cytomegalovirus Infection
by: Aoi Kawamura, et al.
Published: (2025-07-01)

Treatment of Retinal Separation in HIV-infected Patients with Cytomegalovirus Retinitis
by: A. L. Onischenko, et al.
Published: (2017-03-01)

Congenital cytomegalovirus retinitis of prematurity: a case report and literature review
by: Yihui Li, et al.
Published: (2025-04-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2021-02-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method
by: T. N. Komarov, et al.
Published: (2020-05-01)

Challenging problems of congenital cytomegalovirus infection therapy: case study
by: N. V. Rymarenko, et al.
Published: (2024-01-01)

Tackling CMV in Transplant Recipients: Past, Present, and Future
by: Tal Schlaeffer-Yosef, et al.
Published: (2025-04-01)

Dual Resistance to Maribavir and Ganciclovir in Transplant Recipients
by: Steven B. Kleiboeker
Published: (2025-03-01)

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system
by: Haolin Teng, et al.
Published: (2025-05-01)

THE METHOD OF TREATMENT OF GENERALIZED CYTOMEGALOVIRUS INFECTION IN INFANTS
by: S. S. Kochkina, et al.
Published: (2018-04-01)

Cytomegalovirus retinitis with panretinal occlusive vasculopathy concealed by hypertensive uveitis: a case report
by: Seongyong Jeong
Published: (2024-10-01)

Foscarnet Versus Ganciclovir for Severe Congenital Cytomegalovirus Infection: Short- and Long-Term Follow-Up
by: Giovanni Nigro, et al.
Published: (2025-05-01)

Cytomegalovirus Infection in Infants: Course Variants, Modern Approaches to Therapy (Clinical Cases)
by: Irina A. Belyaeva, et al.
Published: (2018-05-01)

Pilot Study of Valganciclovir-Induced Leukopenia in Kidney Transplant Recipients With NUDT15 Genetic Variation
by: Madan M. Bahadur, et al.
Published: (2024-10-01)

Efficacy and toxicity analysis of ganciclovir in patients with cytomegalovirus lung infection: what is new for target range of therapeutic drug monitoring
by: Dongjie Guo, et al.
Published: (2025-08-01)

Congenital cytomegalovirus infection: new answers to old problems
by: Ya. R. Khizhak, et al.
Published: (2024-06-01)

CMV-infection in patients after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Advancements in Cytomegalovirus Management Among Solid Organ Transplant Recipients: Insights From the ESOT CMV Workshop 2023
by: Luca Toti, et al.
Published: (2025-08-01)

Real-world efficacy and safety of letermovir versus ganciclovir prophylaxis in adolescent patients undergoing allogenic hematopoietic stem cell transplantation: a single center observational study
by: Ziwei Xu, et al.
Published: (2025-06-01)

In Silico Analysis of Mechanisms of Maribavir-Induced Inhibition and Drug Resistance Mutations in pUL97 Kinase Structural Prediction with AlphaFold2
by: Jocelyne Piret, et al.
Published: (2025-07-01)

Successfully salvaging a HIV-positive patient with mixed CIDP and meningoencephalitis: a case report
by: Wen Wang, et al.
Published: (2025-03-01)

The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)

Cytomegalovirus Colitis: A Case Report
by: G. V. Tishchenko, et al.
Published: (2024-04-01)

Congenital Cytomegalovirus (cCMV) Infection as a Leading Cause of Pediatric Hearing Loss: Review
by: Amber Cradeur, et al.
Published: (2025-05-01)

Health impact of a hypothetical intervention on immune burden of cytomegalovirus (CMV) among older adults in the US: a prospective analysis of the Health and Retirement Study CohortResearch in context
by: Yuelin He, et al.
Published: (2025-07-01)

Cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: clinical significance and definitions
by: A. A. Dmitrova, et al.
Published: (2022-06-01)

Impact of congenital cytomegalovirus infection on vestibular dysfunction and hearing outcomes in a cohort of children
by: Malesci Rita, et al.
Published: (2025-05-01)

Investigation of the incidence of Toxoplasmosis and cytomegalovirus in patients with thalassemia
by: Ali Yonis Saleh, et al.
Published: (2019-01-01)

Asymptomatic cytomegalovirus gastritis in an immunocompetent COVID-19 patient: a case report
by: Fizza Najeeb, et al.
Published: (2024-06-01)